Clinical Trials Logo
NCT number NCT03497273
Study type Interventional
Source Incyte Corporation
Contact Incyte Corporation Call Center (ex-US)
Phone +800 00027423
Email globalmedinfo@incyte.com
Status Recruiting
Phase Phase 1
Start date March 20, 2018
Completion date April 2019

Clinical Trial Summary

The purpose of this study is to assess the safety and tolerability of itacitinib in combination with corticosteroids in Japanese subjects with Grades II to IV acute graft-versus-host disease (aGVHD).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms